DOI: 10.1016/s0732-8893(99)00092-9. Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates

Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates

10.1016/s0732-8893(99)00092-9

Crossref journal-article

Elsevier BV

Diagnostic Microbiology and Infectious Disease (78)

Bibliography

Gales, A. C., & Jones, R. N. (2000). Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates. Diagnostic Microbiology and Infectious Disease, 36(1), 19â36.

Authors 2

Ana C. Gales (first)
Ronald N. Jones (additional)

References 36 Referenced 134

{'issue': 'RR-12', 'key': '10.1016/S0732-8893(99)00092-9_BIB1', 'first-page': '1', 'article-title': 'Recommendations for perventing the spread of vancomycin-resistance', 'volume': '44', 'author': 'Anonymous', 'year': '1995', 'journal-title': 'Morb Mortal Wkly Rep'} / Morb Mortal Wkly Rep / Recommendations for perventing the spread of vancomycin-resistance by Anonymous (1995)
10.1128/AAC.40.9.2226 / Antimicrob Agents Chemother / Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet (m)- and Tet (o)-mediated ribosomal protection by Bergeron (1996)
10.1093/jac/29.3.245 / J Antimicrob Chemother / Tetracyclines, molecular, and clinical aspects by Chopra (1992)
10.1086/514953 / Clin Infect Dis / Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America by Doern (1998)
10.1128/AAC.38.3.534 / Antimicrob Agents Chemother / In vitro activities of two glycylcyclines against Gram-positive bacteria by Eliopoulos (1994)
10.1093/jac/35.6.877 / J Antimicrob Chemother / In vitro activity of two glycylcyclines against enterococci resistant to other agents by Fraise (1995)
10.1128/AAC.38.9.2218 / Antimicrob Agents Chemother / N,N-Dimethylclycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant Gram-positive by Goldstein (1994)
10.1093/jac/40.1.135 / J Antimicrob Chemother / Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility by Hiramatsu (1997)
10.1016/0732-8893(95)00250-2 / Diagn Microbiol Infect Dis / Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO antimicrobial activity studied against Gram-positive species by Johnson (1996)
10.1016/S0732-8893(98)80002-3 / Diagn Microbiol Infect Dis / Antimicrobial activity of quinupristin/dalfopristin (RP 59500, Synercid™) tested against over 28, 000 recent clinical isolates from 200 medical centers in the United States and Canada by Jones (1998)
10.1128/AAC.40.3.720 / Antimicrob Agents Chemother / In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones by Jones (1996)
10.1016/S0732-8893(98)00108-4 / Diagn Microbiol Infect Dis / Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant Gram-positive bacteria by Jones (1999)
10.1016/S0732-8893(98)00093-5 / Diagn Microbiol Infect Dis / Antimicrobial activity and spectrum of SCH 27899 (Ziracin™) tested against Gram-positive species including recommendations for routine susceptibility testing methods and quality control by Jones (1999)
10.1128/AAC.38.11.2628 / Antimicrob Agents Chemother / Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureplasma urealyticum to new glycylcyclines in comparison with older tetracyclines by Kenny (1994)
10.1093/jac/24.1.1 / J Antimicrob Chemother / Evolution and spread of tetracycline resistance determinants by Levy (1989)
10.1016/S0732-8893(98)00105-9 / Diagn Microbiol Infect Dis / Antimicrobial activity of SCH27899 (Ziracin™), a novel everninomicin derivative, tested against Streptococcus spp. by Marshall (1999)
Mikels, S., Lenoy, E., Allen, W., Compton, S., & Weiss, W. J. (1998). Therapeutic efficacy of GAR-936, a novel glycylcycline, in murine infections (abstr F-135). In: 38thInterscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Sept. 24–27, p. 266.
10.1128/jb.170.12.5522-5528.1988 / J Bacteriol / Characterization of the tetracycline resistance gene of plasmid pT181 Staphylococcus aureus by Mojumdar (1988)
10.1128/AAC.31.10.1648 / Antimicrob Agents Chemother / Energy dependent efflux mediated by Class L (tet L) tetracycline resistance determinant from streptococci by Murry (1987)
National Committee for Clinical Laboratory Standards (NCCLS). (1997). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved standard M7–A4 4th ed. Wayne, PA: NCCLS.
National Committee for Clinical Laboratory Standards (NCCLS). (1997). Methods for dilution antimicrobial susceptibility testing for anaerobic bacteria, Approved standard, M11–A4 4th ed. Wayne, PA: NCCLS.
National Committee for Clinical Laboratory Standards (NCCLS). (1999). Performance standards for antimicrobial susceptibility testing: M100–S9. Wayne, PA: NCCLS.
10.1007/BF02098471 / Eur J Clin Microbiol Infect Dis / In vitro activity of DMG-MINO and DMG-DOT, two new glycylcyclines, against anaerobic bacteria by Nord (1993)
10.1128/AAC.36.5.913 / Antimicrob Agents Chemother / Evidence that tetracyclines analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli by Oliva (1992)
Petersen, P. F., Weiss, W. J., Labthavikul, P., & Bradford, P. A. (1998). The post-antibiotic effect and time kill kinetics of the glycylcyclines, GAR-936 (TBG-MINO), and PAM-MINO (abstr F-132). In: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Sept 24–27, p. 266.
10.1016/S0732-8893(98)00149-7 / Diagn Microbiol Infect Dis / Survey of blood stream infections attributable to Gram-positive cocci by Pfaller (1999)
10.1128/AAC.38.7.1658 / Antimicrob Agents Chemother / Inhibition of protein synthesis occurring on tetracycline-resistant, tet-M protected ribosomes by a novel class of tetracyclines, the glycylcyclines by Rasmussen (1994)
10.1128/CMR.5.4.387 / Clin Microbiol Rev / Bacterial resistance to tetracyclines by Speer (1992)
10.1021/jm00027a023 / J Med Chem / Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines by Sum (1994)
10.1128/AAC.37.11.2270 / Antimicrob Agents Chemother / In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines by Testa (1993)
Van Ogtrop, M. L., Andes, D., Craig, W. C., & Vesga, O. (1998). In vivo activity of two glycylcyclines (GAR-936 and WAY 152, 288) against tetracycline-sensitive and -resistant bacteria (abstr F-133). In: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Sept 24–27, p. 266.
Van Ogtrop, M. L., Andes, D., Craig, W. C., Weiss, W. J., & Vesga, O. (1998). In vivo pharmacodynamic activity of two glycylcyclines (GAR-936 and WAY 152,288) against various Gram-positive andGram-negative bacteria (abstr F-134). In: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Sept 24–27, p. 266.
10.1093/jac/36.1.225 / J Antimicrob Chemother / Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines by Weiss (1995)
Weiss, W. J., Murphy, T., Mikels, S., & Clegg, J. (1998). GAR-936, a novel glycylcycline, in the treatment of experimental endocarditis (abstr F-136). In: 38thInterscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Sept 24–27, p. 267.
10.1128/AAC.38.5.1096 / Antimicrob Agents Chemother / In vitro activities of two glycylcyclines by Wise (1994)
10.1093/clinids/13.5.1023 / Rev Infect Dis / Minocycline as an alternative antistaphylococcal agent by Yuk (1991)

Dates

Type	When
Created	23 years, 1 month ago (July 25, 2002, 7:35 a.m.)
Deposited	5 years, 7 months ago (Jan. 10, 2020, 3:59 a.m.)
Indexed	3 weeks, 4 days ago (Aug. 12, 2025, 5:36 p.m.)
Issued	25 years, 8 months ago (Jan. 1, 2000)
Published	25 years, 8 months ago (Jan. 1, 2000)
Published Print	25 years, 8 months ago (Jan. 1, 2000)

Funders 0

None

BibTeX

@article{Gales_2000, title={Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates}, volume={36}, ISSN={0732-8893}, url={http://dx.doi.org/10.1016/s0732-8893(99)00092-9}, DOI={10.1016/s0732-8893(99)00092-9}, number={1}, journal={Diagnostic Microbiology and Infectious Disease}, publisher={Elsevier BV}, author={Gales, Ana C. and Jones, Ronald N.}, year={2000}, month=jan, pages={19–36} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        12
      ]
    ],
    "date-time": "2025-08-12T21:36:19Z",
    "timestamp": 1755034579635
  },
  "reference-count": 36,
  "publisher": "Elsevier BV",
  "issue": "1",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2000,
            1,
            1
          ]
        ],
        "date-time": "2000-01-01T00:00:00Z",
        "timestamp": 946684800000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2000,
        1
      ]
    ]
  },
  "DOI": "10.1016/s0732-8893(99)00092-9",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        7,
        25
      ]
    ],
    "date-time": "2002-07-25T11:35:32Z",
    "timestamp": 1027596932000
  },
  "page": "19-36",
  "source": "Crossref",
  "is-referenced-by-count": 134,
  "title": "Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates",
  "prefix": "10.1016",
  "volume": "36",
  "author": [
    {
      "given": "Ana C.",
      "family": "Gales",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Ronald N.",
      "family": "Jones",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "issue": "RR-12",
      "key": "10.1016/S0732-8893(99)00092-9_BIB1",
      "first-page": "1",
      "article-title": "Recommendations for perventing the spread of vancomycin-resistance",
      "volume": "44",
      "author": "Anonymous",
      "year": "1995",
      "journal-title": "Morb Mortal Wkly Rep"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB2",
      "doi-asserted-by": "crossref",
      "first-page": "2226",
      "DOI": "10.1128/AAC.40.9.2226",
      "article-title": "Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet (m)- and Tet (o)-mediated ribosomal protection",
      "volume": "40",
      "author": "Bergeron",
      "year": "1996",
      "journal-title": "Antimicrob Agents Chemother"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB3",
      "doi-asserted-by": "crossref",
      "first-page": "245",
      "DOI": "10.1093/jac/29.3.245",
      "article-title": "Tetracyclines, molecular, and clinical aspects",
      "volume": "29",
      "author": "Chopra",
      "year": "1992",
      "journal-title": "J Antimicrob Chemother"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB4",
      "doi-asserted-by": "crossref",
      "first-page": "764",
      "DOI": "10.1086/514953",
      "article-title": "Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America",
      "volume": "27",
      "author": "Doern",
      "year": "1998",
      "journal-title": "Clin Infect Dis"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB5",
      "doi-asserted-by": "crossref",
      "first-page": "534",
      "DOI": "10.1128/AAC.38.3.534",
      "article-title": "In vitro activities of two glycylcyclines against Gram-positive bacteria",
      "volume": "38",
      "author": "Eliopoulos",
      "year": "1994",
      "journal-title": "Antimicrob Agents Chemother"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB6",
      "doi-asserted-by": "crossref",
      "first-page": "877",
      "DOI": "10.1093/jac/35.6.877",
      "article-title": "In vitro activity of two glycylcyclines against enterococci resistant to other agents",
      "volume": "35",
      "author": "Fraise",
      "year": "1995",
      "journal-title": "J Antimicrob Chemother"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB7",
      "doi-asserted-by": "crossref",
      "first-page": "2118",
      "DOI": "10.1128/AAC.38.9.2218",
      "article-title": "N,N-Dimethylclycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant Gram-positive",
      "volume": "38",
      "author": "Goldstein",
      "year": "1994",
      "journal-title": "Antimicrob Agents Chemother"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB8",
      "doi-asserted-by": "crossref",
      "first-page": "135",
      "DOI": "10.1093/jac/40.1.135",
      "article-title": "Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility",
      "volume": "40",
      "author": "Hiramatsu",
      "year": "1997",
      "journal-title": "J Antimicrob Chemother"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB9",
      "doi-asserted-by": "crossref",
      "first-page": "53",
      "DOI": "10.1016/0732-8893(95)00250-2",
      "article-title": "Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO antimicrobial activity studied against Gram-positive species",
      "volume": "24",
      "author": "Johnson",
      "year": "1996",
      "journal-title": "Diagn Microbiol Infect Dis"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB10",
      "doi-asserted-by": "crossref",
      "first-page": "437",
      "DOI": "10.1016/S0732-8893(98)80002-3",
      "article-title": "Antimicrobial activity of quinupristin/dalfopristin (RP 59500, Synercid\u2122) tested against over 28, 000 recent clinical isolates from 200 medical centers in the United States and Canada",
      "volume": "30",
      "author": "Jones",
      "year": "1998",
      "journal-title": "Diagn Microbiol Infect Dis"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB11",
      "doi-asserted-by": "crossref",
      "first-page": "720",
      "DOI": "10.1128/AAC.40.3.720",
      "article-title": "In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones",
      "volume": "40",
      "author": "Jones",
      "year": "1996",
      "journal-title": "Antimicrob Agents Chemother"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB12",
      "doi-asserted-by": "crossref",
      "first-page": "101",
      "DOI": "10.1016/S0732-8893(98)00108-4",
      "article-title": "Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant Gram-positive bacteria",
      "volume": "33",
      "author": "Jones",
      "year": "1999",
      "journal-title": "Diagn Microbiol Infect Dis"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB13",
      "doi-asserted-by": "crossref",
      "first-page": "103",
      "DOI": "10.1016/S0732-8893(98)00093-5",
      "article-title": "Antimicrobial activity and spectrum of SCH 27899 (Ziracin\u2122) tested against Gram-positive species including recommendations for routine susceptibility testing methods and quality control",
      "volume": "34",
      "author": "Jones",
      "year": "1999",
      "journal-title": "Diagn Microbiol Infect Dis"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB14",
      "doi-asserted-by": "crossref",
      "first-page": "2628",
      "DOI": "10.1128/AAC.38.11.2628",
      "article-title": "Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureplasma urealyticum to new glycylcyclines in comparison with older tetracyclines",
      "volume": "38",
      "author": "Kenny",
      "year": "1994",
      "journal-title": "Antimicrob Agents Chemother"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB15",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1093/jac/24.1.1",
      "article-title": "Evolution and spread of tetracycline resistance determinants",
      "volume": "24",
      "author": "Levy",
      "year": "1989",
      "journal-title": "J Antimicrob Chemother"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB16",
      "doi-asserted-by": "crossref",
      "first-page": "19",
      "DOI": "10.1016/S0732-8893(98)00105-9",
      "article-title": "Antimicrobial activity of SCH27899 (Ziracin\u2122), a novel everninomicin derivative, tested against Streptococcus spp.",
      "volume": "33",
      "author": "Marshall",
      "year": "1999",
      "journal-title": "Diagn Microbiol Infect Dis"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB17",
      "unstructured": "Mikels, S., Lenoy, E., Allen, W., Compton, S., & Weiss, W. J. (1998). Therapeutic efficacy of GAR-936, a novel glycylcycline, in murine infections (abstr F-135). In: 38thInterscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Sept. 24\u201327, p. 266."
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB18",
      "doi-asserted-by": "crossref",
      "first-page": "5522",
      "DOI": "10.1128/jb.170.12.5522-5528.1988",
      "article-title": "Characterization of the tetracycline resistance gene of plasmid pT181 Staphylococcus aureus",
      "volume": "170",
      "author": "Mojumdar",
      "year": "1988",
      "journal-title": "J Bacteriol"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB19",
      "doi-asserted-by": "crossref",
      "first-page": "1648",
      "DOI": "10.1128/AAC.31.10.1648",
      "article-title": "Energy dependent efflux mediated by Class L (tet L) tetracycline resistance determinant from streptococci",
      "volume": "31",
      "author": "Murry",
      "year": "1987",
      "journal-title": "Antimicrob Agents Chemother"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB20",
      "unstructured": "National Committee for Clinical Laboratory Standards (NCCLS). (1997). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved standard M7\u2013A4 4th ed. Wayne, PA: NCCLS."
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB21",
      "unstructured": "National Committee for Clinical Laboratory Standards (NCCLS). (1997). Methods for dilution antimicrobial susceptibility testing for anaerobic bacteria, Approved standard, M11\u2013A4 4th ed. Wayne, PA: NCCLS."
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB22",
      "unstructured": "National Committee for Clinical Laboratory Standards (NCCLS). (1999). Performance standards for antimicrobial susceptibility testing: M100\u2013S9. Wayne, PA: NCCLS."
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB23",
      "doi-asserted-by": "crossref",
      "first-page": "784",
      "DOI": "10.1007/BF02098471",
      "article-title": "In vitro activity of DMG-MINO and DMG-DOT, two new glycylcyclines, against anaerobic bacteria",
      "volume": "12",
      "author": "Nord",
      "year": "1993",
      "journal-title": "Eur J Clin Microbiol Infect Dis"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB24",
      "doi-asserted-by": "crossref",
      "first-page": "913",
      "DOI": "10.1128/AAC.36.5.913",
      "article-title": "Evidence that tetracyclines analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli",
      "volume": "36",
      "author": "Oliva",
      "year": "1992",
      "journal-title": "Antimicrob Agents Chemother"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB25",
      "unstructured": "Petersen, P. F., Weiss, W. J., Labthavikul, P., & Bradford, P. A. (1998). The post-antibiotic effect and time kill kinetics of the glycylcyclines, GAR-936 (TBG-MINO), and PAM-MINO (abstr F-132). In: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Sept 24\u201327, p. 266."
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB26",
      "doi-asserted-by": "crossref",
      "first-page": "283",
      "DOI": "10.1016/S0732-8893(98)00149-7",
      "article-title": "Survey of blood stream infections attributable to Gram-positive cocci",
      "volume": "33",
      "author": "Pfaller",
      "year": "1999",
      "journal-title": "Diagn Microbiol Infect Dis"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB27",
      "doi-asserted-by": "crossref",
      "first-page": "1658",
      "DOI": "10.1128/AAC.38.7.1658",
      "article-title": "Inhibition of protein synthesis occurring on tetracycline-resistant, tet-M protected ribosomes by a novel class of tetracyclines, the glycylcyclines",
      "volume": "38",
      "author": "Rasmussen",
      "year": "1994",
      "journal-title": "Antimicrob Agents Chemother"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB28",
      "doi-asserted-by": "crossref",
      "first-page": "387",
      "DOI": "10.1128/CMR.5.4.387",
      "article-title": "Bacterial resistance to tetracyclines",
      "volume": "5",
      "author": "Speer",
      "year": "1992",
      "journal-title": "Clin Microbiol Rev"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB29",
      "doi-asserted-by": "crossref",
      "first-page": "184",
      "DOI": "10.1021/jm00027a023",
      "article-title": "Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines",
      "volume": "37",
      "author": "Sum",
      "year": "1994",
      "journal-title": "J Med Chem"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB30",
      "doi-asserted-by": "crossref",
      "first-page": "2270",
      "DOI": "10.1128/AAC.37.11.2270",
      "article-title": "In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines",
      "volume": "37",
      "author": "Testa",
      "year": "1993",
      "journal-title": "Antimicrob Agents Chemother"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB31",
      "unstructured": "Van Ogtrop, M. L., Andes, D., Craig, W. C., & Vesga, O. (1998). In vivo activity of two glycylcyclines (GAR-936 and WAY 152, 288) against tetracycline-sensitive and -resistant bacteria (abstr F-133). In: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Sept 24\u201327, p. 266."
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB32",
      "unstructured": "Van Ogtrop, M. L., Andes, D., Craig, W. C., Weiss, W. J., & Vesga, O. (1998). In vivo pharmacodynamic activity of two glycylcyclines (GAR-936 and WAY 152,288) against various Gram-positive andGram-negative bacteria (abstr F-134). In: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Sept 24\u201327, p. 266."
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB33",
      "doi-asserted-by": "crossref",
      "first-page": "225",
      "DOI": "10.1093/jac/36.1.225",
      "article-title": "Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines",
      "volume": "36",
      "author": "Weiss",
      "year": "1995",
      "journal-title": "J Antimicrob Chemother"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB34",
      "unstructured": "Weiss, W. J., Murphy, T., Mikels, S., & Clegg, J. (1998). GAR-936, a novel glycylcycline, in the treatment of experimental endocarditis (abstr F-136). In: 38thInterscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Sept 24\u201327, p. 267."
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB35",
      "doi-asserted-by": "crossref",
      "first-page": "1096",
      "DOI": "10.1128/AAC.38.5.1096",
      "article-title": "In vitro activities of two glycylcyclines",
      "volume": "38",
      "author": "Wise",
      "year": "1994",
      "journal-title": "Antimicrob Agents Chemother"
    },
    {
      "key": "10.1016/S0732-8893(99)00092-9_BIB36",
      "doi-asserted-by": "crossref",
      "first-page": "1023",
      "DOI": "10.1093/clinids/13.5.1023",
      "article-title": "Minocycline as an alternative antistaphylococcal agent",
      "volume": "13",
      "author": "Yuk",
      "year": "1991",
      "journal-title": "Rev Infect Dis"
    }
  ],
  "container-title": "Diagnostic Microbiology and Infectious Disease",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0732889399000929?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0732889399000929?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2020,
        1,
        10
      ]
    ],
    "date-time": "2020-01-10T08:59:47Z",
    "timestamp": 1578646787000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0732889399000929"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2000,
        1
      ]
    ]
  },
  "references-count": 36,
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2000,
          1
        ]
      ]
    }
  },
  "alternative-id": [
    "S0732889399000929"
  ],
  "URL": "http://dx.doi.org/10.1016/S0732-8893(99)00092-9",
  "relation": {},
  "ISSN": [
    "0732-8893"
  ],
  "subject": [],
  "container-title-short": "Diagnostic Microbiology and Infectious Disease",
  "published": {
    "date-parts": [
      [
        2000,
        1
      ]
    ]
  }
}